Entero Healthcare's IPO has a fresh issue of INR 1000 cr & an offer to sell shares worth INR 600 cr for debt repayment, working capital, acquisitions, and sustainability.
IPO Date: Feb 9 to Feb 13, 2024 IPO Listing Date: Feb 16, 2024 IPO Price: INR 1195-1258 per share IPO Lot Size: 11 Shares IPO Total Issue Size: Approx INR 600 crores
Entero Healthcare shows revenue growth but persistent losses pre-IPO, indicating a high-risk, potential-reward investment, stressing future profitability.
Entero Healthcare posts ₹33,057M income, -₹3.10 EPS, vs. MedPlus's healthier finances with ₹4.17 EPS, 3.36% RoNW, showcasing stark contrasts.
Entero Healthcare's IPO aims to repay debt (INR 123.67 cr), fund working capital (INR 600 cr), pursue acquisitions for growth, and enhance corporate sustainability.
Entero Healthcare faces risks from failed acquisitions, supply chain issues, and high capital needs, impacting operations and financial prospects.
Disclaimer:
*T&C Apply